alternatives to glp-1 agonists The and Obesity: How Diabetes Drugs are Changing Non-Diabetic Lives — tl;dr pharmacy Closest medical alternatives to tirzepatide:

The unimolecular dual incretins were more successful than selective monoagonists and tackled the two basic causes of diabetes: pancreatic insulin insufficiency and obesity-induced insulin resistance

References 1.Ng M., Fleming T., Robinson M., Thomson B., Graetz N., Margono C., Mullany E.C., Biryukov S., Abbafati C., Abera S.F., et al

doi:10.1111/j.1463-1326.2008.01018.x 36

The distinction between evidence-based pharmaceutical GLP-1 medications and unregulated patch products is critical for patient safety and treatment efficacy

SmartPill, a novel ambulatory diagnostic test for measuring gastric emptying in health and disease

You can also use HSA or FSA funds to reduce costs further